{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:55:26Z","timestamp":1793084126826,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006088","name":"National Center for Emerging and Zoonotic Infectious Diseases","doi-asserted-by":"publisher","award":["RFA-CK-13-001"],"award-info":[{"award-number":["RFA-CK-13-001"]}],"id":[{"id":"10.13039\/100006088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uganda has experienced seven Ebola Virus Disease (EVD) outbreaks and four Marburg Virus Disease (MVD) outbreaks between 2000 and 2019. We investigated the seroprevalence and risk factors for Marburg virus and ebolaviruses in gold mining communities around Kitaka gold mine in Western Uganda and compared them to non-mining communities in Central Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A questionnaire was administered and human blood samples were collected from three exposure groups in Western Uganda (gold miners, household members of miners, non-miners living within 50\u2009km of Kitaka mine). The unexposed controls group sampled was community members in Central Uganda far away from any gold mining activity which we considered as low-risk for filovirus infection. ELISA serology was used to analyse samples, detecting IgG antibodies against Marburg virus and ebolaviruses (filoviruses). Data were analysed in STATA software using risk ratios and odds ratios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Miners in western Uganda were 5.4 times more likely to be filovirus seropositive compared to the control group in central Uganda (RR\u2009=\u20095.4; 95% CI 1.5\u201319.7) whereas people living in high-risk areas in Ibanda and Kamwenge districts were 3.6 more likely to be seropositive compared to control group in Luweeero district (RR\u2009=\u20093.6; 95% CI 1.1\u201312.2). Among all participants, filovirus seropositivity was 2.6% (19\/724) of which 2.3% (17\/724) were reactive to Sudan virus only and 0.1% (1\/724) to Marburg virus. One individual seropositive for Sudan virus also had IgG antibodies reactive to Bundibugyo virus. The risk factors for filovirus seropositivity identified included mining (AOR\u2009=\u20093.4; 95% CI 1.3\u20138.5), male sex (AOR\u2009=\u20093.1; 95% CI 1.01\u20139.5), going inside mines (AOR\u2009=\u20093.1; 95% CI 1.2\u20138.2), cleaning corpses (AOR\u2009=\u20093.1; 95% CI 1.04\u20139.1) and contact with suspect filovirus cases (AOR\u2009=\u20093.9, 95% CI 1.04\u201314.5).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings indicate that filovirus outbreaks may go undetected in Uganda and people involved in artisan gold mining are more likely to be exposed to infection with either Marburg virus or ebolaviruses, likely due to increased risk of exposure to bats. This calls for active surveillance in known high-risk areas for early detection and response to prevent filovirus epidemics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05187-0","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T03:53:05Z","timestamp":1593575585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-9157","authenticated-orcid":false,"given":"Luke","family":"Nyakarahuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana J.","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Balinandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Mulei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Tumusiime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Kyondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Knust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Lutwama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Rollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"5187_CR1","doi-asserted-by":"publisher","unstructured":"Nyakarahuka L, Kankya C, Krontveit R, Mayer B, Mwiine FNFN, Lutwama J, et al. How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence. BMC Infect Dis. 2016;16:708. https:\/\/doi.org\/10.1186\/s12879-016-2045-6.","DOI":"10.1186\/s12879-016-2045-6"},{"key":"5187_CR2","doi-asserted-by":"publisher","unstructured":"Knust B, Schafer IJIJ, Wamala J, Nyakarahuka L, Okot C, Shoemaker T, et al. Multidistrict outbreak of Marburg virus disease - Uganda, 2012. J Infect Dis. 2015;212 Suppl 2(Suppl 2):S119-28. https:\/\/doi.org\/10.1093\/infdis\/jiv351.","DOI":"10.1093\/infdis\/jiv351"},{"key":"5187_CR3","doi-asserted-by":"publisher","unstructured":"Adjemian J, Farnon EC, Tschioko F, Wamala JF, Byaruhanga E, Bwire GS, et al. Outbreak of Marburg hemorrhagic fever among miners in kamwenge and ibanda Districts, Uganda, 2007. J Infect Dis 2011;204 Suppl 3(Suppl 3):S796\u20139. https:\/\/doi.org\/10.1093\/infdis\/jir312.","DOI":"10.1093\/infdis\/jir312"},{"key":"5187_CR4","doi-asserted-by":"publisher","unstructured":"Towner JS, Amman BR, Sealy TK, Reeder Carroll SA, Comer JA, Kemp A, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 2009;5(7):e1000536. https:\/\/doi.org\/10.1371\/journal.ppat.1000536.","DOI":"10.1371\/journal.ppat.1000536"},{"key":"5187_CR5","doi-asserted-by":"publisher","unstructured":"Amman BR, Carroll SA, Reed ZD, Sealy TK, Balinandi S, Swanepoel R, et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 2012;8(10):e1002877. https:\/\/doi.org\/10.1371\/journal.ppat.1002877.","DOI":"10.1371\/journal.ppat.1002877"},{"key":"5187_CR6","doi-asserted-by":"publisher","unstructured":"Amman BRBRBR, Nyakarahuka L, McElroy AKAK, Dodd KAKA, Sealy TKTK, Schuh AJAJ, et al. Marburgvirus resurgence in Kitaka mine bat population after extermination attempts, Uganda. 2014;20(10):1761\u201364. https:\/\/doi.org\/10.3201\/eid2010.140696.","DOI":"10.3201\/eid2010.140696"},{"key":"5187_CR7","unstructured":"Bennett S, Woods T, Liyanage WM, Smith DL. A simplified general method for cluster-sample surveys of health in developing countries. World Health Statistics Quarterly. 1991;44(3):98\u2013106."},{"key":"5187_CR8","doi-asserted-by":"publisher","unstructured":"Viera AJ. Odds ratios and risk ratios: What\u2019s the difference and why does it matter? South Med J. 2008;101(7):730\u20134. https:\/\/doi.org\/10.1097\/SMJ.0b013e31817a7ee4.","DOI":"10.1097\/SMJ.0b013e31817a7ee4"},{"issue":"Suppl","key":"5187_CR9","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1086\/514313","volume":"179","author":"TG Ksiazek","year":"1999","unstructured":"Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis. 1999;179(Suppl):S192\u20138.","journal-title":"J Infect Dis"},{"key":"5187_CR10","doi-asserted-by":"publisher","unstructured":"Knust B, Schafer IJ, Wamala J, Nyakarahuka L, Okot C, Shoemaker T, Dodd K, Gibbons A, Balinandi S, Tumusiime A, Campbell S, Newman E, Lasry E, DeClerck H, Boum Y, Makumbi I, Bosa HK, Mbonye A, Aceng JR, Nichol ST, Rollin PE. Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012. J Infect Dis. 2015;212 Suppl 2(Suppl 2):S119\u2013S128. https:\/\/doi.org\/10.1093\/infdis\/jiv351.","DOI":"10.1093\/infdis\/jiv351"},{"key":"5187_CR11","doi-asserted-by":"publisher","unstructured":"Mathiot CC, Georges AJ, Fontenille D, Coulanges P. Antibodies to haemorrhagic fever viruses in Madagascar populations. Trans R Soc Trop Med Hyg. 1989;83(3):407\u20139. https:\/\/doi.org\/10.1016\/0035-9203(89)90519-1.","DOI":"10.1016\/0035-9203(89)90519-1"},{"key":"5187_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00193395","volume":"181","author":"S Becker","year":"1992","unstructured":"Becker S, Feldmann H, Will C, Slenczka W. Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? Med Microbiol Immunol. 1992;181:43\u201355.","journal-title":"Med Microbiol Immunol"},{"key":"5187_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/0035-9203(83)90216-X","volume":"77","author":"BK Johnson","year":"1983","unstructured":"Johnson BK, Ocheng D, Gichogo A, Okiro M, Libondo D, Tukei PM, et al. Antibodies against haemorrhagic fever viruses in Kenya populations. Trans R Soc Trop Med Hyg. 1983;77:731\u20133.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5187_CR14","first-page":"209","volume":"38","author":"FW van der Waals","year":"1986","unstructured":"van der Waals FW, Pomeroy KL, Goudsmit J, Asher DM, Gajdusek DC. Hemorrhagic fever virus infections in an isolated rainforest area of Central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. Trop Geogr Med. 1986;38:209\u201314.","journal-title":"Trop Geogr Med"},{"key":"5187_CR15","doi-asserted-by":"publisher","unstructured":"Gonzalez JP, Josse R, Johnson ED, Merlin M, Georges AJ, Abandja J, et al. Antibody prevalence against haemorrhagic fever viruses in randomized representative central African populations. Res Virol. 1989;140(4):319\u201331. https:\/\/doi.org\/10.1016\/s0923-2516(89)80112-8.","DOI":"10.1016\/s0923-2516(89)80112-8"},{"key":"5187_CR16","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/0035-9203(93)90077-4","volume":"87","author":"ED Johnson","year":"1993","unstructured":"Johnson ED, Gonzalez JP, Georges A. Filovirus activity among selected ethnic-groups inhabiting the tropical Forest of equatorial Africa. Trans R Soc Trop Med Hyg. 1993;87:536\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5187_CR17","doi-asserted-by":"publisher","unstructured":"Johnson ED, Gonzalez JP, Georges A. Haemorrhagic fever virus activity in equatorial africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic. Trans R Soc Trop Med Hyg. 1993;87(5):530\u20135. https:\/\/doi.org\/10.1016\/0035-9203(93)90075-2.","DOI":"10.1016\/0035-9203(93)90075-2"},{"key":"5187_CR18","doi-asserted-by":"publisher","unstructured":"Schuh AJ, Amman BR, Sealy TK. et al. Egyptian rousette bats maintain long-term protective immunity against Marburg virus infection despite diminished antibody levels. Sci Rep. 2017;7:8763. https:\/\/doi.org\/10.1038\/s41598-017-07824-2.","DOI":"10.1038\/s41598-017-07824-2"},{"key":"5187_CR19","doi-asserted-by":"crossref","unstructured":"Nkoghe D, Padilla C, Becquart P, Wauquier N, Moussavou G, Aku\u00e9 JP, et al. Risk factors for zaire ebolavirus-specific IgG in rural gabonese populations. J Infect Dis. 2011;204 SUPPL. 3.","DOI":"10.1093\/infdis\/jir344"},{"key":"5187_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1286-4579(00)00287-2","volume":"2","author":"JPJP Gonzalez","year":"2000","unstructured":"Gonzalez JPJP, Nakoune E, Slenczka W, Vidal P, Morvan JJM. Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic. Microbes Infect. 2000;2:39\u201344. https:\/\/doi.org\/10.1016\/S1286-4579(00)00287-2.","journal-title":"Microbes Infect"},{"key":"5187_CR21","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3201\/eid0912.030355","volume":"9","author":"DG Bausch","year":"2003","unstructured":"Bausch DG, Borchert M, Grein T, Roth C, Swanepoel R, Libande ML, et al. Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis. 2003;9:1531\u20137. https:\/\/doi.org\/10.3201\/eid0912.030355.","journal-title":"Emerg Infect Dis"},{"key":"5187_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4269\/ajtmh.1988.38.407","volume":"38","author":"O Tomori","year":"1988","unstructured":"Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg. 1988;38:407\u201310.","journal-title":"Am J Trop Med Hyg."},{"key":"5187_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/ije\/dyv307","volume":"45","author":"J Brainard","year":"2016","unstructured":"Brainard J, Hooper L, Pond K, Edmunds K, Hunter PR. Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis. Int J Epidemiol. 2016;45:102\u201316.","journal-title":"Int J Epidemiol"},{"key":"5187_CR24","doi-asserted-by":"publisher","unstructured":"WHO Ebola Response Team, Aylward B, Barboza P, et al. Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371(16):1481\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1411100.","DOI":"10.1056\/NEJMoa1411100"},{"key":"5187_CR25","doi-asserted-by":"publisher","unstructured":"Bower H, Glynn JR. A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection. Scientific Data. 2017;4:160133. https:\/\/doi.org\/10.1038\/sdata.2016.133.","DOI":"10.1038\/sdata.2016.133"},{"key":"5187_CR26","doi-asserted-by":"publisher","unstructured":"Glynn JR, Bower H, Johnson S, Houlihan CF, Montesano C, Scott JT, et al. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infect Dis. 2017;17(6):645\u201353. https:\/\/doi.org\/10.1016\/S1473-3099(17)30111-1.","DOI":"10.1016\/S1473-3099(17)30111-1"},{"issue":"Suppl","key":"5187_CR27","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1086\/514309","volume":"179","author":"KM Busico","year":"1999","unstructured":"Busico KM, Marshall KL, Ksiazek TG, Roels TH, Fleerackers Y, Feldmann H, et al. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl):S102\u20137.","journal-title":"J Infect Dis"},{"key":"5187_CR28","doi-asserted-by":"publisher","unstructured":"Becquart P, Wauquier N, Mahlak\u00f5iv T, Nkoghe D, Padilla C, Souris M, et al. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One. 2010;5(2):e9126. https:\/\/doi.org\/10.1371\/journal.pone.0009126.","DOI":"10.1371\/journal.pone.0009126"},{"key":"5187_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/infdis\/142.3.372","volume":"142","author":"DL Heymann","year":"1980","unstructured":"Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis. 1980;142:372\u20136.","journal-title":"J Infect Dis"},{"key":"5187_CR30","unstructured":"Van Der Groen G, Pattyn SR. Measurement of antibodies to Ebola virus in human sera from N.W.-Zaire. Ann Soc Belg Med Trop (1920). 1979;59(1):87\u201392."},{"key":"5187_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3201\/eid1103.040981","volume":"11","author":"L Allela","year":"2005","unstructured":"Allela L, Bourry O, Pouillot R, D\u00e9licat A, Yaba P, Kumulungui B, et al. Ebola virus antibody prevalence in dogs and human risk. Emerg Infect Dis. 2005;11:385\u201390.","journal-title":"Emerg Infect Dis"},{"key":"5187_CR32","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1086\/427994","volume":"191","author":"RT Heffernan","year":"2005","unstructured":"Heffernan RT, Pambo B, Hatchett RJ, Leman PA, Swanepoel R, Ryder RW. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogoou\u00e9-Ivindo region, northeastern Gabon, 1997. J Infect Dis. 2005;191:964\u20138.","journal-title":"J Infect Dis"},{"key":"5187_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.trstmh.2006.07.002","volume":"101","author":"SA Lahm","year":"2007","unstructured":"Lahm SA, Kombila M, Swanepoel R, Barnes RFWW. Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. Trans R Soc Trop Med Hyg. 2007;101:64\u201378.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl","key":"5187_CR34","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1086\/514290","volume":"179","author":"AJ Georges","year":"1999","unstructured":"Georges AJ, Leroy EM, Renaut AA, Benissan CT, Nabias RJ, Ngoc MT, et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis. 1999;179(Suppl):S65\u201375.","journal-title":"J Infect Dis"},{"key":"5187_CR35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.4269\/ajtmh.1999.60.610","volume":"60","author":"E Bertherat","year":"1999","unstructured":"Bertherat E, Renaut A, Nabias R, Dubreuil G, Georges-Courbot MC. Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. Am J Trop Med Hyg. 1999;60:610\u20135.","journal-title":"Am J Trop Med Hyg."},{"key":"5187_CR36","first-page":"997","volume":"61","author":"RC Baron","year":"1983","unstructured":"Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 1983;61:997\u20131003.","journal-title":"Bull World Health Organ"},{"key":"5187_CR37","first-page":"51","volume":"80","author":"DM Meunier","year":"1987","unstructured":"Meunier DM, Johnson ED, Gonzalez JP, Georges-Courbot MC, Madelon MC, Georges AJ. Current serologic data on viral hemorrhagic fevers in the Central African Republic. Bull Soc Pathol Exot Filiales. 1987;80:51\u201361.","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"5187_CR38","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.4269\/ajtmh.1983.32.1465","volume":"32","author":"P Bouree","year":"1983","unstructured":"Bouree P, Bergmann J-FF. Ebola virus infection in man: a serological and epidemiological survey in the Cameroons. Am J Trop Med Hyg. 1983;32:1465\u20136. https:\/\/doi.org\/10.4269\/ajtmh.1983.32.1465.","journal-title":"Am J Trop Med Hyg"},{"key":"5187_CR39","first-page":"679","volume":"81","author":"MA Paix","year":"1988","unstructured":"Paix MA, Poveda JD, Malvy D, Bailly C, Merlin M, Fleury HJ. Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon. Bull Soc Pathol Exot Filiales. 1988;81:679\u201382.","journal-title":"Bull Soc Pathol Exot Filiales."},{"key":"5187_CR40","doi-asserted-by":"publisher","unstructured":"MacNeil A, Reed Z, Rollin PE. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl Trop Dis. 2011;5(6):e1175. https:\/\/doi.org\/10.1371\/journal.pntd.0001175.","DOI":"10.1371\/journal.pntd.0001175"},{"key":"5187_CR41","doi-asserted-by":"publisher","unstructured":"Natesan M, Jensen SM, Keasey SL, Kamata T, Kuehne AI, Stonier SW, et al. Human survivors of disease outbreaks caused by Ebola or Marburg virus exhibit cross-reactive and long-lived antibody responses. Clin Vaccine Immunol. 2016;23(8):717\u201324. https:\/\/doi.org\/10.1128\/CVI.00107-16.","DOI":"10.1128\/CVI.00107-16"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05187-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05187-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05187-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T20:14:02Z","timestamp":1625084042000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05187-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5187"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05187-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20899\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20899\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"6 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the Uganda Ministry of Health National Taskforce (NTF) on Ebola and Marburg virus outbreaks to conduct this study as a follow up to the 2012 Marburg outbreak. Additionally, approval from CDC was obtained through a determination that the investigations were a follow-up to the MVD outbreak and was classified as non-research. Approval (No. HS 1538) from the UVRI Research and Ethics Committee and the National Council of Science and Technology was obtained. Written consent was obtained from each study participant and for those below 18\u2009years, permission was provided by their parent or guardian.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no competing interest in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"461"}}